title: Treatment of hepatitis C in a pediatric patient using simeprevir and sofosbuvir immediately after an umbilical cord blood transplantation.
authors.affiliation: Department of Immunology, St. Jude Children's Research Hospital, University of Tennessee Health Science Center, College of Medicine, Memphis, TN, USA.
authors.forename: P
authors.initials: P
authors.lastname: Thomas
authors.affiliation: Department of Pathology, St. Jude Children's Research Hospital, University of Tennessee Health Science Center, College of Medicine, Memphis, TN, USA.
authors.forename: T
authors.initials: T
authors.lastname: Santiago
authors.affiliation: Department of Bone Marrow Transplantation and Cellular Therapy St. Jude Children's Research Hospital, University of Tennessee Health Science Center, College of Medicine, Memphis, TN, USA.|Department of Pediatrics, University of Tennessee Health Science Center, College of Medicine, Memphis, TN, USA.
authors.forename: M H
authors.initials: MH
authors.lastname: Dallas
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D001706:Biopsy; D002675:Child, Preschool; D036101:Cord Blood Stem Cell Transplantation; D005260:Female; D005312:Fetal Blood; D005838:Genotype; D016174:Hepacivirus; D006526:Hepatitis C / Q000188:drug therapy / Q000628:therapy*; D006801:Humans; D007165:Immunosuppression Therapy; D008099:Liver / Q000473:pathology; D000069616:Simeprevir / Q000627:therapeutic use*; D000069474:Sofosbuvir / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents; D000069616:Simeprevir; D000069474:Sofosbuvir